They indicate that an increased MMP-9 level in the acute phase of ischemic stroke was associated with three-month cognitive impairment, independent of adopted risk factors; this is consistent with our present data indicating that the pre-rehabilitation level of MMP-9 gene expression was negatively correlated with an improvement in cognition (Table 5) [56]. This evidence concerns the gene MMP9 and Cognitive impairment.